Statins Reduce Some Lymphomas in Veterans With HIV

Statins appear to have immunomodulatory and anti-inflammatory effects and appear to reduce cancer risk. A new study sought to determine if that also is the case with HIV patients, who experience chronic inflammation and immune activation.

AML Prognosis Improved With Promising Therapy Combinations

HOUSTON—The prognosis for older patients with acute myeloid leukemia (AML) has remained dismal, even after treatment with a hypomethylating agent. Standard curative treatment for AML, which is primarily a disease of older adults with a median age of 68 years at...

Prognosis Beginning to Improve for T-cell Lymphoma Patients

LONG BEACH, CA – Among hematological malignancies, T-cell lymphomas have an extremely poor prognosis. A new review suggested that might be changing with unusual paths to cure. An article in the Lancet Haematology pointed out that, over the last three decades, little...

VA Dramatically Reduces ESA Use for Cancer-Related Anemia

COLUMBIA, SC -- Erythropoiesis-stimulating agents were indicated for use in patients with cancer who receive noncurative myelosuppressive chemotherapy, with the intention of mitigating symptoms and side effects to decrease the need for red blood cell transfusions....

Is Radiation Therapy Linked to Second Cancer Diagnoses?

STANFORD, CA – How likely is a second cancer diagnosis after primary cancer treatment with 3-dimensional conformal radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT), or proton beam radiotherapy (PBRT) for lymphoma and other cancers? Researchers from...

Changes in Myelofibrosis Survival at VA

HOUSTON — Myelofibrosis Is a rare disorder in which abnormal blood cells and fibers build up in the bone marrow. It is classified as a myeloproliferative neoplasm (MPNs) in which bone marrow cells that produce blood cells develop and function abnormally....